225 related articles for article (PubMed ID: 11489469)
1. AC133 antigen as a prognostic factor in acute leukemia.
Lee ST; Jang JH; Min YH; Hahn JS; Ko YW
Leuk Res; 2001 Sep; 25(9):757-67. PubMed ID: 11489469
[TBL] [Abstract][Full Text] [Related]
2. [Expression of AC133 vs. CD34 in acute childhood leukemias].
Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S
Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777
[TBL] [Abstract][Full Text] [Related]
3. Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping.
Wuchter C; Ratei R; Spahn G; Schoch C; Harbott J; Schnittger S; Haferlach T; Creutzig U; Sperling C; Karawajew L; Ludwig WD
Haematologica; 2001 Feb; 86(2):154-61. PubMed ID: 11224484
[TBL] [Abstract][Full Text] [Related]
4. AC133 expression on acute myeloid leukemia blasts: correlation to FAB and to CD34 expression and possible implications for peripheral blood progenitor cell purging in AML.
Fauth F; Weidmann E; Martin H; Schneider B; Sonnhoff S; Hoelzer D
Leuk Res; 2001 Mar; 25(3):191-6. PubMed ID: 11226513
[TBL] [Abstract][Full Text] [Related]
5. AC133 expression in egyptian children with acute leukemia: impact on treatment response and disease outcome.
Elgendi HM; Mekawy MA; Abdel Wahab SE; Tawfik LM; Ismail EA; Adly AA
J Pediatr Hematol Oncol; 2010 May; 32(4):286-93. PubMed ID: 20224439
[TBL] [Abstract][Full Text] [Related]
6. [The expression and clinical significance of early differentiation antigens in acute leukemia].
Zhou Y; Li Q; Meng HX; Wang YF; Yu Z; Qiu LG
Zhonghua Nei Ke Za Zhi; 2005 Jan; 44(1):46-9. PubMed ID: 15769398
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein (P-170) and CD34 expression in adult acute myeloid leukemia (AML).
Lamy T; Goasguen JE; Mordelet E; Grulois I; Dauriac C; Drenou B; Chaperon J; Fauchet R; le Prise PY
Leukemia; 1994 Nov; 8(11):1879-83. PubMed ID: 7526090
[TBL] [Abstract][Full Text] [Related]
8. [The expression of CD133 in acute leukemia and its clinical significance].
Zhou Y; Meng HX; Yu Z; Li Q; Wang YF; Mai YJ; Han JL; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):401-4. PubMed ID: 15355691
[TBL] [Abstract][Full Text] [Related]
9. CD117/CD34 expression in leukemic blasts.
Wells SJ; Bray RA; Stempora LL; Farhi DC
Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172
[TBL] [Abstract][Full Text] [Related]
10. Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients.
Feller N; van der Pol MA; Waaijman T; Weijers GW; Westra G; Ossenkoppele GJ; Schuurhuis GJ
Clin Cancer Res; 2005 Jul; 11(13):4793-801. PubMed ID: 16000576
[TBL] [Abstract][Full Text] [Related]
11. Expression, regulation and function of AC133, a putative cell surface marker of primitive human haematopoietic cells.
Majka M; Ratajczak J; Machalinski B; Carter A; Pizzini D; Wasik MA; Gewirtz AM; Ratajczak MZ
Folia Histochem Cytobiol; 2000; 38(2):53-63. PubMed ID: 10833669
[TBL] [Abstract][Full Text] [Related]
12. Detection of molecular targets on the surface of CD34+CD38- bone marrow cells in myelodysplastic syndromes.
Xie W; Wang X; Du W; Liu W; Qin X; Huang S
Cytometry A; 2010 Sep; 77(9):840-8. PubMed ID: 20662087
[TBL] [Abstract][Full Text] [Related]
13. Leukemia-associated changes identified by quantitative flow cytometry. IV. CD34 overexpression in acute myelogenous leukemia M2 with t(8;21).
Porwit-MacDonald A; Janossy G; Ivory K; Swirsky D; Peters R; Wheatley K; Walker H; Turker A; Goldstone AH; Burnett A
Blood; 1996 Feb; 87(3):1162-9. PubMed ID: 8562943
[TBL] [Abstract][Full Text] [Related]
14. Salvage therapy in refractory acute myeloid leukemia: prediction of outcome based on analysis of prognostic factors.
Tavernier E; Le QH; Elhamri M; Thomas X
Leuk Res; 2003 Mar; 27(3):205-14. PubMed ID: 12537972
[TBL] [Abstract][Full Text] [Related]
15. Discordant expression of AC133 and AC141 in patients with myelodysplastic syndrome (MDS) and acute myelogeneous leukemia (AML).
Green CL; Loken M; Buck D; Deeg HJ
Leukemia; 2000 Apr; 14(4):770-2. PubMed ID: 10764169
[No Abstract] [Full Text] [Related]
16. Expression of vascular endothelial growth factor receptor 3 and Tie1 tyrosine kinase receptor on acute leukemia cells.
Kivivuori SM; Siitonen S; Porkka K; Vettenranta K; Alitalo R; Saarinen-Pihkala U
Pediatr Blood Cancer; 2007 Apr; 48(4):387-92. PubMed ID: 16685739
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD133 in acute leukemia.
Tolba FM; Foda ME; Kamal HM; Elshabrawy DA
Med Oncol; 2013 Jun; 30(2):527. PubMed ID: 23532815
[TBL] [Abstract][Full Text] [Related]
18. Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My10).
Geller RB; Zahurak M; Hurwitz CA; Burke PJ; Karp JE; Piantadosi S; Civin CI
Br J Haematol; 1990 Nov; 76(3):340-7. PubMed ID: 1702006
[TBL] [Abstract][Full Text] [Related]
19. In leukemic hematopoiesis CD34 antigen does not have the same significance as it does normal hematopoiesis.
Del CaƱizo MC; Galende J; Mota A; Orfao A; Martinez A; Almeida J; San Miguel JF
Leuk Res; 1997 Jul; 21(7):651-6. PubMed ID: 9301686
[TBL] [Abstract][Full Text] [Related]
20. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
Al-Mawali A; Gillis D; Lewis I
J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]